基蛋生物科技股份有限公司关于完成工商变更登记及备案并取得营业执照的公告

Core Viewpoint - The company has completed the registration and obtained a new business license following the cancellation of its supervisory board and amendments to its articles of association [1] Group 1: Corporate Actions - The company held its first extraordinary general meeting on September 15, 2025, where it approved the proposal to cancel the supervisory board and amend the articles of association [1] - The company also convened a workers' representative meeting on the same day to elect representatives to the fourth board of directors [1] Group 2: Business License Details - The company has received a new business license from the Nanjing Market Supervision Administration, with the following details: - Unified Social Credit Code: 913201007360621166 - Name: 基蛋生物科技股份有限公司 (G-Bio Technology Co., Ltd.) - Type: Joint-stock company (listed, natural person investment or control) - Address: No. 9, Bofu Road, Yangtze River Industrial Development Zone, Liuhe District, Nanjing - Legal Representative: Su Enben - Registered Capital: 507.153517 million yuan - Establishment Date: March 8, 2002 [1] Group 3: Business Scope - The company is engaged in the production and operation of medical devices, including: - Production of Class II and Class III medical devices - Operation and leasing of Class III medical devices - Inspection and testing services [1] - Additional business activities include: - Technical services, development, consulting, and transfer - Production and sales of Class I and Class II medical devices - Software sales and development - Import and export agency services [1]